TY - CONF T1 - Enhancement and Size-based Response Criteria for Evaluating Tyrosine Kinase Inhibitor Dosing Strategy in Metastatic Renal Cancer: Prospective Imaging Study from the UK STAR Trial JO - CLINICAL ONCOLOGY PY - 2024/01/01 AU - Manickavasagar T AU - Kelly-Morland C AU - Wah TM AU - Nathan P AU - Brown J AU - Goh V ED - VL - 36 IS - 1 SP - E78 EP - E79 Y2 - 2025/05/25 ER -